{"doi":"10.1016/j.ebiom.2023.104562","title":"Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory","abstract":"BACKGROUND: This analysis evaluated the immune response to the two-dose, heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen, administered 56-days apart, from multiple African sites based on results from one analytic laboratory. METHODS: Solutions laboratory at baseline, 21 days (EBL2002 and EBL3001) or 28 days (EBL2004) post-dose 2 (regimen completion), and 12 months post-dose 1 using the validated Filovirus Animal Nonclinical Group Ebola glycoprotein enzyme-linked immunosorbent assay (ELISA). Responders were defined as those with a >2.5-fold increase from baseline or the lower limit of quantification (LLOQ) if <LLOQ at baseline. FINDINGS: At 21 or 28 (21/28) days post-dose 2, the geometric mean concentration (GMC) range was 3810-7518 ELISA units (EU)/mL (percent responders: ≥98%) in adults, 9929-13532 EU/mL (≥98%) in adolescents aged 12-17 years, 10,212-17388 EU/mL (≥99%) in older children, and 22,568-25111 EU/mL (≥98%) in younger children. When stratified by country, GMCs at 21/28 days post-dose 2 were generally similar among adults and within paediatric cohorts (percent responders: 95%-100%). At month 12, GMC range was 259-437 EU/mL (percent responders: 49%-88%) in adults and 386-1139 EU/mL (70%-100%) in paediatric participants. INTERPRETATION: Based on data from a single laboratory using a single validated assay, Ad26.ZEBOV, MVA-BN-Filo induced a strong humoral immune response, with ≥95% of participants across countries classified as responders at 21/28 days post-dose 2 (regimen completion), regardless of age. FUNDING: Janssen Vaccines & Prevention BV; Innovative Medicines Initiative.","journal":"EBioMedicine","year":2023,"id":330668,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":10,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.6719,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1054930,"name":"Houreratou Barry","orcid":"0000-0001-8114-1240","position":1,"is_corresponding":false},{"id":588602,"name":"Mark Kieh","orcid":null,"position":2,"is_corresponding":false},{"id":1054931,"name":"Zacchaeus Anywaine","orcid":"0000-0001-5771-5515","position":3,"is_corresponding":false},{"id":639623,"name":"Baimba Rogers","orcid":null,"position":4,"is_corresponding":false},{"id":262078,"name":"Seydou Doumbia","orcid":"0000-0003-1637-5600","position":5,"is_corresponding":false},{"id":653483,"name":"Sodiomon B. Sirima","orcid":"0000-0002-0972-4211","position":6,"is_corresponding":false},{"id":639624,"name":"Alimamy Serry-Bangura","orcid":null,"position":7,"is_corresponding":false},{"id":588259,"name":"Abdoul Habib Béavogui","orcid":"0000-0003-4950-6224","position":8,"is_corresponding":false},{"id":466910,"name":"Auguste Gaddah","orcid":"0009-0009-1545-6338","position":9,"is_corresponding":false},{"id":1054932,"name":"Michael Katwere","orcid":"0000-0001-7917-289X","position":10,"is_corresponding":false},{"id":303943,"name":"Jenny Hendriks","orcid":"0009-0008-8191-6200","position":11,"is_corresponding":false},{"id":638728,"name":"Babajide Keshinro","orcid":"0000-0003-4673-2955","position":12,"is_corresponding":false},{"id":614024,"name":"Serge Eholié","orcid":null,"position":13,"is_corresponding":false},{"id":347963,"name":"Hannah Kibuuka","orcid":"0000-0002-2293-1944","position":14,"is_corresponding":false},{"id":96873,"name":"Stephen B. Kennedy","orcid":"0000-0002-0318-930X","position":15,"is_corresponding":false},{"id":495103,"name":"Omu Anzala","orcid":"0000-0001-5186-1415","position":16,"is_corresponding":false},{"id":479793,"name":"Mohamed Samai","orcid":"0000-0002-1427-9482","position":17,"is_corresponding":false},{"id":588264,"name":"Éric D’Ortenzio","orcid":"0000-0002-4527-6209","position":18,"is_corresponding":false},{"id":588603,"name":"Bailah Leigh","orcid":null,"position":19,"is_corresponding":false},{"id":299788,"name":"Samba O. Sow","orcid":"0000-0002-6335-5066","position":20,"is_corresponding":false},{"id":646420,"name":"Rodolphe Thiébaut","orcid":"0000-0002-5235-3962","position":21,"is_corresponding":false},{"id":588265,"name":"Brian Greenwood","orcid":"0000-0001-5725-9118","position":22,"is_corresponding":false},{"id":588263,"name":"Deborah Watson‐Jones","orcid":"0000-0001-6247-1746","position":23,"is_corresponding":false},{"id":303949,"name":"Macaya Douoguih","orcid":"0000-0002-2707-5729","position":24,"is_corresponding":false},{"id":303950,"name":"Kerstin Lühn","orcid":"0000-0001-8451-1294","position":25,"is_corresponding":false},{"id":303948,"name":"Cynthia Robinson","orcid":"0000-0002-0219-4123","position":26,"is_corresponding":false},{"id":329303,"name":"Chelsea McLean","orcid":"0000-0002-3548-3482","position":0,"is_corresponding":true}],"reference_count":20,"raw_metadata":null,"created_at":"2026-07-19T01:09:14.691473Z","pmid":"37099841","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}